Europe Aurora Kinase A Market Report 2018

2018-06-13 / 3450.00 / Chemical & Materials / 114 Pages

Description

Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Aurora Kinase A for these regions, from 2012 to 2023 (forecast), including
Germany
UK
France
Russia
Benelux
Italy
Spain

Europe Aurora Kinase A market competition by top manufacturers/players, with Aurora Kinase A sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
AbbVie Inc.
Amgen Inc.
Astex Pharmaceuticals, Inc.
CASI Pharmaceuticals Inc.
Merck & Co., Inc.
Millennium Pharmaceuticals, Inc.
Sanofi
Sareum Holdings Plc
Sigma-Tau S.p.A.
Taiho Pharmaceutical Co., Ltd.
Vertex Pharmaceuticals Incorporated
Vichem Chemie Research Ltd.

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
AMG-900
Danusertib
ENMD-2076
Ilorasertib
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Aurora Kinase A for each application, including
Ovarian Cancer
Anaplastic Large Cell Lymphoma
Brain Tumor
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Content

Table of Contents

Europe Aurora Kinase A Market Report 2012-2023
1 Aurora Kinase A Overview
1.1 Product Overview and Scope of Aurora Kinase A
1.2 Classification of Aurora Kinase A by Product Category
1.2.1 Europe Aurora Kinase A Sales (K Units) Comparison by Types (2012-2023)
1.2.2 Europe Aurora Kinase A Sales (K Units) Market Share by Types in 2017
1.2.3 AMG-900
1.2.4 Danusertib
1.2.5 ENMD-2076
1.2.6 Ilorasertib
1.2.7 Others
1.3 Europe Aurora Kinase A Market by Application/End Users
1.3.1 Europe Aurora Kinase A (K Units) and Market Share Comparison by Applications (2012-2023)
1.3.2 Ovarian Cancer
1.3.3 Anaplastic Large Cell Lymphoma
1.3.4 Brain Tumor
1.3.5 Others
1.4 Europe Aurora Kinase A Market by Region
1.4.1 Europe Aurora Kinase A Revenue (Million USD) Comparison by Regions (2012-2023)
1.4.2 Germany Status and Prospect (2012-2023)
1.4.3 UK Status and Prospect (2012-2023)
1.4.4 France Status and Prospect (2012-2023)
1.4.5 Russia Status and Prospect (2012-2023)
1.4.6 Benelux Status and Prospect (2012-2023)
1.4.7 Italy Status and Prospect (2012-2023)
1.4.8 Spain Status and Prospect (2012-2023)
1.5 Europe Sales and Revenue ofSales and Revenue of Aurora Kinase A (2012-2023)
1.5.1 Europe Aurora Kinase A Sales (K Units) and Growth Rate (2012-2023)
1.5.2 Europe Aurora Kinase A Revenue (Million USD) and Growth Rate (2012-2023)

2 Industrial Chain Analysis
2.1 Industry Chain Structure of Aurora Kinase A
2.2 Raw Material Analysis of Aurora Kinase A
2.1.1 Raw Material A Market Analysis
2.1.2 Raw Material B Market Analysis
2.1.3 Raw Material C Market Analysis
2.3 Labor Cost Analysis of Aurora Kinase A
2.4 Other Costs Analysis of Aurora Kinase A
2.5 Manufacturing Cost Structure Analysis of Aurora Kinase A
2.6 Manufacturing Process Analysis of Aurora Kinase A
2.7 Raw Materials Sources of Aurora Kinase A Major Manufacturers in 2018
2.8 Downstream Buyers

3 Europe Aurora Kinase A Players/Suppliers Profiles and Sales Data
3.1 AbbVie Inc.
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Aurora Kinase A Product Category, Application and Specification
3.1.2.1 Product A
3.1.2.2 Product B
3.1.3 AbbVie Inc. Aurora Kinase A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.1.4 AbbVie Inc. Different Types of Aurora Kinase A Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.1.5 AbbVie Inc. Aurora Kinase A Volume in Different Applications and Its Application Share
3.2 Amgen Inc.
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Aurora Kinase A Product Category, Application and Specification
3.2.2.1 Product A
3.2.2.2 Product B
3.2.3 Amgen Inc. Aurora Kinase A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.2.4 Amgen Inc. Different Types of Aurora Kinase A Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.2.5 Amgen Inc. Aurora Kinase A Volume in Different Applications and Its Application Share
3.3 Astex Pharmaceuticals, Inc.
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Aurora Kinase A Product Category, Application and Specification
3.3.2.1 Product A
3.3.2.2 Product B
3.3.3 Astex Pharmaceuticals, Inc. Aurora Kinase A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.3.4 Astex Pharmaceuticals, Inc. Different Types of Aurora Kinase A Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.3.5 Astex Pharmaceuticals, Inc. Aurora Kinase A Volume in Different Applications and Its Application Share
3.4 CASI Pharmaceuticals Inc.
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Aurora Kinase A Product Category, Application and Specification
3.4.2.1 Product A
3.4.2.2 Product B
3.4.3 CASI Pharmaceuticals Inc. Aurora Kinase A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.4.4 CASI Pharmaceuticals Inc. Different Types of Aurora Kinase A Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.4.5 CASI Pharmaceuticals Inc. Aurora Kinase A Volume in Different Applications and Its Application Share
3.5 Merck & Co., Inc.
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Aurora Kinase A Product Category, Application and Specification
3.5.2.1 Product A
3.5.2.2 Product B
3.5.3 Merck & Co., Inc. Aurora Kinase A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.5.4 Merck & Co., Inc. Different Types of Aurora Kinase A Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.5.5 Merck & Co., Inc. Aurora Kinase A Volume in Different Applications and Its Application Share
3.6 Millennium Pharmaceuticals, Inc.
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Aurora Kinase A Product Category, Application and Specification
3.6.2.1 Product A
3.6.2.2 Product B
3.6.3 Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.6.4 Millennium Pharmaceuticals, Inc. Different Types of Aurora Kinase A Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.6.5 Millennium Pharmaceuticals, Inc. Aurora Kinase A Volume in Different Applications and Its Application Share
3.7 Sanofi
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Aurora Kinase A Product Category, Application and Specification
3.7.2.1 Product A
3.7.2.2 Product B
3.7.3 Sanofi Aurora Kinase A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.7.4 Sanofi Different Types of Aurora Kinase A Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.7.5 Sanofi Aurora Kinase A Volume in Different Applications and Its Application Share
3.8 Sareum Holdings Plc
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Aurora Kinase A Product Category, Application and Specification
3.8.2.1 Product A
3.8.2.2 Product B
3.8.3 Sareum Holdings Plc Aurora Kinase A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.8.4 Sareum Holdings Plc Different Types of Aurora Kinase A Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.8.5 Sareum Holdings Plc Aurora Kinase A Volume in Different Applications and Its Application Share
3.9 Sigma-Tau S.p.A.
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Aurora Kinase A Product Category, Application and Specification
3.9.2.1 Product A
3.9.2.2 Product B
3.9.3 Sigma-Tau S.p.A. Aurora Kinase A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.9.4 Sigma-Tau S.p.A. Different Types of Aurora Kinase A Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.9.5 Sigma-Tau S.p.A. Aurora Kinase A Volume in Different Applications and Its Application Share
3.10 Taiho Pharmaceutical Co., Ltd.
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Aurora Kinase A Product Category, Application and Specification
3.10.2.1 Product A
3.10.2.2 Product B
3.10.3 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.10.4 Taiho Pharmaceutical Co., Ltd. Different Types of Aurora Kinase A Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.10.5 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Volume in Different Applications and Its Application Share
3.11 Vertex Pharmaceuticals Incorporated
3.12 Vichem Chemie Research Ltd.

4 Europe Aurora Kinase A Competition by Players/Manufacturers, Region, Type and Application
4.1 Europe Aurora Kinase A Market Competition by Players/Manufacturers
4.1.1 Europe Aurora Kinase A Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017)
4.1.2 Europe Aurora Kinase A Revenue (Million USD) and Share by Players/Suppliers (2012-2017)
4.2 Europe Aurora Kinase A Sales and Revenue by Type
4.2.1 Europe Aurora Kinase A Sales (K Units) and Market Share by Type (2012-2017)
4.2.2 Europe Aurora Kinase A Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 Europe Aurora Kinase A Sales and Revenue by Application
4.3.1 Europe Aurora Kinase A Sales (K Units) and Market Share by Regions (2012-2017)
4.3.2 Europe Aurora Kinase A Revenue (Million USD) and Market Share (%) Regions (2012-2017)
4.4 Europe Aurora Kinase A Sales (K Units) by Application

5 Germany Aurora Kinase A (Sales, Revenue and Price)
5.1 Germany Aurora Kinase A Sales and Value (2012-2017)
5.1.1 Germany Aurora Kinase A Sales (K Units) and Growth Rate (2012-2017)
5.1.2 Germany Aurora Kinase A Revenue and Growth Rate (2012-2017)
5.1.3 Germany Aurora Kinase A Sales Price (USD/Unit) Trend (2012-2017)
5.2 Germany Aurora Kinase A Sales (K Units) and Market Share by Type
5.3 Germany Aurora Kinase A Sales (K Units) and Market Share by Application

6 UK Aurora Kinase A (Sales, Revenue and Price)
6.1 UK Aurora Kinase A Sales and Value (2012-2017)
6.1.1 UK Aurora Kinase A Sales (K Units) and Growth Rate (2012-2017)
6.1.2 UK Aurora Kinase A Revenue and Growth Rate (2012-2017)
6.1.3 UK Aurora Kinase A Sales Price (USD/Unit) Trend (2012-2017)
6.2 UK Aurora Kinase A Sales (K Units) and Market Share by Type
6.3 UK Aurora Kinase A Sales (K Units) and Market Share by Application

7 France Aurora Kinase A (Sales, Revenue and Price)
7.1 France Aurora Kinase A Sales and Value (2012-2017)
7.1.1 France Aurora Kinase A Sales (K Units) and Growth Rate (2012-2017)
7.1.2 France Aurora Kinase A Revenue and Growth Rate (2012-2017)
7.1.3 France Aurora Kinase A Sales Price (USD/Unit) Trend (2012-2017)
7.2 France Aurora Kinase A Sales (K Units) and Market Share by Type
7.3 France Aurora Kinase A Sales (K Units) and Market Share by Application

8 Russia Aurora Kinase A (Sales, Revenue and Price)
8.1 Russia Aurora Kinase A Sales and Value (2012-2017)
8.1.1 Russia Aurora Kinase A Sales (K Units) and Growth Rate (2012-2017)
8.1.2 Russia Aurora Kinase A Revenue and Growth Rate (2012-2017)
8.1.3 Russia Aurora Kinase A Sales Price (USD/Unit) Trend (2012-2017)
8.2 Russia Aurora Kinase A Sales (K Units) and Market Share by Type
8.3 Russia Aurora Kinase A Sales (K Units) and Market Share by Application

9 Benelux Aurora Kinase A (Sales, Revenue and Price)
9.1 Benelux Aurora Kinase A Sales and Value (2012-2017)
9.1.1 Benelux Aurora Kinase A Sales (K Units) and Growth Rate (2012-2017)
9.1.2 Benelux Aurora Kinase A Revenue and Growth Rate (2012-2017)
9.1.3 Benelux Aurora Kinase A Sales Price (USD/Unit) Trend (2012-2017)
9.2 Benelux Aurora Kinase A Sales (K Units) and Market Share by Type
9.3 Benelux Aurora Kinase A Sales (K Units) and Market Share by Application

10 Italy Aurora Kinase A (Sales, Revenue and Price)
10.1 Italy Aurora Kinase A Sales and Value (2012-2017)
10.1.1 Italy Aurora Kinase A Sales (K Units) and Growth Rate (2012-2017)
10.1.2 Italy Aurora Kinase A Revenue and Growth Rate (2012-2017)
10.1.3 Italy Aurora Kinase A Sales Price (USD/Unit) Trend (2012-2017)
10.2 Italy Aurora Kinase A Sales (K Units) and Market Share by Type
10.3 Italy Aurora Kinase A Sales (K Units) and Market Share by Application

11 Spain Aurora Kinase A (Sales, Revenue and Price)
11.1 Spain Aurora Kinase A Sales and Value (2012-2017)
11.1.1 Spain Aurora Kinase A Sales (K Units) and Growth Rate (2012-2017)
11.1.2 Spain Aurora Kinase A Revenue and Growth Rate (2012-2017)
11.1.3 Spain Aurora Kinase A Sales Price (USD/Unit) Trend (2012-2017)
11.2 Spain Aurora Kinase A Sales (K Units) and Market Share by Type
11.3 Spain Aurora Kinase A Sales (K Units) and Market Share by Application

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Direct Marketing
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Europe Aurora Kinase A Market Forecast (2018-2023)
13.1 Europe Aurora Kinase A Sales (K Units), Revenue and Price Forecast (2018-2023)
13.1.1 Europe Aurora Kinase A Sales (K Units) and Growth Rate Forecast (2018-2023)
13.1.2 Europe Aurora Kinase A Revenue and Growth Rate Forecast (2018-2023)
13.1.3 Europe Aurora Kinase A Price and Trend Forecast (2018-2023)
13.2 Europe Aurora Kinase A Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023)
13.2.1 Europe Aurora Kinase A Sales (K Units) and Growth Rate Forecast by Region (2018-2023)
13.2.2 Europe Aurora Kinase A Revenue and Growth Rate Forecast by Region (2018-2023)
13.2.3 Germany Aurora Kinase A Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.4 UK Aurora Kinase A Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.5 France Aurora Kinase A Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.6 Russia Aurora Kinase A Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.7 France Aurora Kinase A Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.8 Italy Aurora Kinase A Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.9 Spain Aurora Kinase A Sales, Revenue and Growth Rate Forecast (2018-2023)
13.3 Europe Aurora Kinase A Sales, Revenue and Price Forecast by Type (2018-2023)
13.3.1 Europe Aurora Kinase A Sales Forecast by Type (2018-2023)
13.3.2 Europe Aurora Kinase A Revenue Forecast by Type (2018-2023)
13.3.3 Europe Aurora Kinase A Price Forecast by Type (2018-2023)
13.4 Europe Aurora Kinase A Sales Forecast by Application (2018-2023)

14 Research Findings and Conclusion

15 Appendix
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Disclaimer



Table of Figures

List of Tables and Figures

Figure Europe Market Size (Million USD) Comparison 2012-2023
Table Europe Market Aurora Kinase A Revenue (Million USD) Comparison by Regions 2012-2023
Table Europe Aurora Kinase A Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Europe Aurora Kinase A Sales (K Units) by Application (2016-2023)
Figure Product Picture of Aurora Kinase A
Table Europe Aurora Kinase A Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023)
Figure Europe Aurora Kinase A Sales (K Units) Market Share by Types in 2017
Figure AMG-900 Picture
Figure Danusertib Picture
Figure ENMD-2076 Picture
Table Europe Aurora Kinase A Sales (K Units) Comparison by Applications (2012-2023)
Figure Europe Sales Market Share of Aurora Kinase A by Applications in 2017
Figure Ovarian Cancer Picture
Figure Anaplastic Large Cell Lymphoma Picture
Figure Brain Tumor Picture
Table Europe Market Aurora Kinase A Revenue (Million USD) Comparison by Regions 2012-2023
Figure Germany Aurora Kinase A Revenue (Million USD) and Growth Rate (2012-2023)
Figure UK Aurora Kinase A Revenue (Million USD) and Growth Rate (2012-2023)
Figure France Aurora Kinase A Revenue (Million USD) and Growth Rate (2012-2023)
Figure Russia Aurora Kinase A Revenue (Million USD) and Growth Rate (2012-2023)
Figure Benelux Aurora Kinase A Revenue (Million USD) and Growth Rate (2012-2023)
Figure Italy Aurora Kinase A Revenue (Million USD) and Growth Rate (2012-2023)
Figure Spain Aurora Kinase A Revenue (Million USD) and Growth Rate (2012-2023)
Figure Europe Aurora Kinase A Sales (K Units) and Growth Rate (2012-2023)
Figure Europe Aurora Kinase A Revenue (Million USD) and Growth Rate (2012-2023)
Figure New Project SWOT Analysis of Aurora Kinase A
Table Industry News List of Aurora Kinase A
Figure Industry Chain Structure of Aurora Kinase A
Table Raw Material Suppliers and Price Analysis
Figure Global Raw Material A Price Trend (USD/MT)
Figure Global Raw Material B Price Trend (USD/MT)
Figure Global Raw Material C Price Trend (USD/MT)
Table Manufacturing Cost Structure Analysis of Aurora Kinase A in 2017
Figure Manufacturing Process Analysis of Aurora Kinase A
Table Raw Materials Sources of Aurora Kinase A Major Manufacturers Europe
Table Major Buyers of Aurora Kinase A
Table AbbVie Inc. Basic Information List
Table AbbVie Inc. Aurora Kinase A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure AbbVie Inc. Aurora Kinase A Sales Growth Rate (2012-2017)
Figure AbbVie Inc. Aurora Kinase A Sales Europe Market Share (%) (2012-2017)
Figure AbbVie Inc. Aurora Kinase A Revenue Europe Market Share (%) (2012-2017)
Table AMG-900 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Danusertib Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table ENMD-2076 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table AbbVie Inc. Aurora Kinase A Volume in Ovarian Cancer and Its Application Share
Table AbbVie Inc. Aurora Kinase A Volume in Anaplastic Large Cell Lymphoma and Its Application Share
Table AbbVie Inc. Aurora Kinase A Volume in Brain Tumor and Its Application Share
Table Amgen Inc. Basic Information List
Table Amgen Inc. Aurora Kinase A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Amgen Inc. Aurora Kinase A Sales Growth Rate (2012-2017)
Figure Amgen Inc. Aurora Kinase A Sales Europe Market Share (%) (2012-2017)
Figure Amgen Inc. Aurora Kinase A Revenue Europe Market Share (%) (2012-2017)
Table AMG-900 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Danusertib Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table ENMD-2076 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Amgen Inc. Aurora Kinase A Volume in Ovarian Cancer and Its Application Share
Table Amgen Inc. Aurora Kinase A Volume in Anaplastic Large Cell Lymphoma and Its Application Share
Table Amgen Inc. Aurora Kinase A Volume in Brain Tumor and Its Application Share
Table Astex Pharmaceuticals, Inc. Basic Information List
Table Astex Pharmaceuticals, Inc. Aurora Kinase A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Astex Pharmaceuticals, Inc. Aurora Kinase A Sales Growth Rate (2012-2017)
Figure Astex Pharmaceuticals, Inc. Aurora Kinase A Sales Europe Market Share (%) (2012-2017)
Figure Astex Pharmaceuticals, Inc. Aurora Kinase A Revenue Europe Market Share (%) (2012-2017)
Table AMG-900 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Danusertib Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table ENMD-2076 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Astex Pharmaceuticals, Inc. Aurora Kinase A Volume in Ovarian Cancer and Its Application Share
Table Astex Pharmaceuticals, Inc. Aurora Kinase A Volume in Anaplastic Large Cell Lymphoma and Its Application Share
Table Astex Pharmaceuticals, Inc. Aurora Kinase A Volume in Brain Tumor and Its Application Share
Table CASI Pharmaceuticals Inc. Basic Information List
Table CASI Pharmaceuticals Inc. Aurora Kinase A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure CASI Pharmaceuticals Inc. Aurora Kinase A Sales Growth Rate (2012-2017)
Figure CASI Pharmaceuticals Inc. Aurora Kinase A Sales Europe Market Share (%) (2012-2017)
Figure CASI Pharmaceuticals Inc. Aurora Kinase A Revenue Europe Market Share (%) (2012-2017)
Table AMG-900 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Danusertib Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table ENMD-2076 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table CASI Pharmaceuticals Inc. Aurora Kinase A Volume in Ovarian Cancer and Its Application Share
Table CASI Pharmaceuticals Inc. Aurora Kinase A Volume in Anaplastic Large Cell Lymphoma and Its Application Share
Table CASI Pharmaceuticals Inc. Aurora Kinase A Volume in Brain Tumor and Its Application Share
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Aurora Kinase A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Merck & Co., Inc. Aurora Kinase A Sales Growth Rate (2012-2017)
Figure Merck & Co., Inc. Aurora Kinase A Sales Europe Market Share (%) (2012-2017)
Figure Merck & Co., Inc. Aurora Kinase A Revenue Europe Market Share (%) (2012-2017)
Table AMG-900 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Danusertib Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table ENMD-2076 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Merck & Co., Inc. Aurora Kinase A Volume in Ovarian Cancer and Its Application Share
Table Merck & Co., Inc. Aurora Kinase A Volume in Anaplastic Large Cell Lymphoma and Its Application Share
Table Merck & Co., Inc. Aurora Kinase A Volume in Brain Tumor and Its Application Share
Table Millennium Pharmaceuticals, Inc. Basic Information List
Table Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales Growth Rate (2012-2017)
Figure Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales Europe Market Share (%) (2012-2017)
Figure Millennium Pharmaceuticals, Inc. Aurora Kinase A Revenue Europe Market Share (%) (2012-2017)
Table AMG-900 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Danusertib Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table ENMD-2076 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Millennium Pharmaceuticals, Inc. Aurora Kinase A Volume in Ovarian Cancer and Its Application Share
Table Millennium Pharmaceuticals, Inc. Aurora Kinase A Volume in Anaplastic Large Cell Lymphoma and Its Application Share
Table Millennium Pharmaceuticals, Inc. Aurora Kinase A Volume in Brain Tumor and Its Application Share
Table Sanofi Basic Information List
Table Sanofi Aurora Kinase A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Sanofi Aurora Kinase A Sales Growth Rate (2012-2017)
Figure Sanofi Aurora Kinase A Sales Europe Market Share (%) (2012-2017)
Figure Sanofi Aurora Kinase A Revenue Europe Market Share (%) (2012-2017)
Table AMG-900 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Danusertib Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table ENMD-2076 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Sanofi Aurora Kinase A Volume in Ovarian Cancer and Its Application Share
Table Sanofi Aurora Kinase A Volume in Anaplastic Large Cell Lymphoma and Its Application Share
Table Sanofi Aurora Kinase A Volume in Brain Tumor and Its Application Share
Table Sareum Holdings Plc Basic Information List
Table Sareum Holdings Plc Aurora Kinase A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Sareum Holdings Plc Aurora Kinase A Sales Growth Rate (2012-2017)
Figure Sareum Holdings Plc Aurora Kinase A Sales Europe Market Share (%) (2012-2017)
Figure Sareum Holdings Plc Aurora Kinase A Revenue Europe Market Share (%) (2012-2017)
Table AMG-900 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Danusertib Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table ENMD-2076 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Sareum Holdings Plc Aurora Kinase A Volume in Ovarian Cancer and Its Application Share
Table Sareum Holdings Plc Aurora Kinase A Volume in Anaplastic Large Cell Lymphoma and Its Application Share
Table Sareum Holdings Plc Aurora Kinase A Volume in Brain Tumor and Its Application Share
Table Sigma-Tau S.p.A. Basic Information List
Table Sigma-Tau S.p.A. Aurora Kinase A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Sigma-Tau S.p.A. Aurora Kinase A Sales Growth Rate (2012-2017)
Figure Sigma-Tau S.p.A. Aurora Kinase A Sales Europe Market Share (%) (2012-2017)
Figure Sigma-Tau S.p.A. Aurora Kinase A Revenue Europe Market Share (%) (2012-2017)
Table AMG-900 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Danusertib Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table ENMD-2076 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Sigma-Tau S.p.A. Aurora Kinase A Volume in Ovarian Cancer and Its Application Share
Table Sigma-Tau S.p.A. Aurora Kinase A Volume in Anaplastic Large Cell Lymphoma and Its Application Share
Table Sigma-Tau S.p.A. Aurora Kinase A Volume in Brain Tumor and Its Application Share
Table Company Taiho Pharmaceutical Co., Ltd. Basic Information List
Table Company Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Company Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales Growth Rate (2012-2017)
Figure Company Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales Europe Market Share (%) (2012-2017)
Figure Company Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Revenue Europe Market Share (%) (2012-2017)
Table AMG-900 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Danusertib Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table ENMD-2076 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Company Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Volume in Ovarian Cancer and Its Application Share
Table Company Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Volume in Anaplastic Large Cell Lymphoma and Its Application Share
Table Company Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Volume in Brain Tumor and Its Application Share
Table Europe Aurora Kinase A Sales (K Units) by Players/Manufacturers (2012-2017)
Table Europe Aurora Kinase A Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 Europe Aurora Kinase A Sales Market Share (%) by Players/Manufacturers
Figure 2017 Europe Aurora Kinase A Sales Share by Players/Manufacturers
Table Europe Aurora Kinase A Revenue (Million USD) by Players/Manufacturers (2012-2017)
Table Europe Aurora Kinase A Revenue Market Share (%) Players/Manufacturers (2012-2017)
Figure 2016 Europe Aurora Kinase A Revenue Market Share (%) Players
Figure 2017 Europe Aurora Kinase A Revenue Market Share (%) Players
Table Europe Aurora Kinase A Sales (K Units) and Market Share (%) by Type (2012-2017)
Table Europe Aurora Kinase A Sales Share by Type (2012-2017)
Figure Sales Market Share of Aurora Kinase A by Type (2012-2017)
Figure Europe Aurora Kinase A Sales Growth Rate (%) by Type (2012-2017)
Table Europe Aurora Kinase A Revenue (Million USD) and Market Share (%) Type (2012-2017)
Table Europe Aurora Kinase A Revenue Market Share (%) Type (2012-2017)
Figure Revenue Market Share of Aurora Kinase A by Type (2012-2017)
Figure Europe Aurora Kinase A Revenue Growth Rate by Type (2012-2017)
Table Europe Aurora Kinase A Sales (K Units) and Market Share by Regions (2012-2017)
Table Europe Aurora Kinase A Sales Share by Regions (2012-2017)
Figure Sales Market Share of Aurora Kinase A by Regions (2012-2017)
Figure Europe Aurora Kinase A Sales Market Share by Regions in 2017
Table Europe Aurora Kinase A Revenue (Million USD) and Market Share by Regions (2012-2017)
Table Europe Aurora Kinase A Revenue Share (%) by Regions (2012-2017)
Figure Revenue Market Share of Aurora Kinase A by Regions (2012-2017)
Figure Europe Aurora Kinase A Revenue Market Share by Regions in 2017
Table Europe Aurora Kinase A Sales (K Units) and Market Share by Application (2012-2017)
Table Europe Aurora Kinase A Sales Share (%) by Application (2012-2017)
Figure Europe Aurora Kinase A Sales Market Share by Application (2012-2017)
Figure Europe Aurora Kinase A Sales Market Share by Application (2012-2017)
Figure Germany Aurora Kinase A Sales (K Units) and Growth Rate (%) (2012-2017)
Figure Germany Aurora Kinase A Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Germany Aurora Kinase A Sales Price (USD/Unit) Trend (2012-2017)
Table Germany Aurora Kinase A Sales (K Units) by Type (2012-2017)
Table Germany Aurora Kinase A Sales (K Units) Market Share by Type (2012-2017)
Figure Germany Aurora Kinase A Sales (K Units) Market Share by Type in 2017
Table Germany Aurora Kinase A Sales (K Units) by Applications (2012-2017)
Table Germany Aurora Kinase A Sales (K Units) Market Share by Applications (2012-2017)
Figure Germany Aurora Kinase A Sales (K Units) Market Share by Applications in 2017
Figure UK Aurora Kinase A Sales (K Units) and Growth Rate (2012-2017)
Figure UK Aurora Kinase A Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure UK Aurora Kinase A Sales Price (USD/Unit) Trend (2012-2017)
Table UK Aurora Kinase A Sales (K Units) by Type (2012-2017)
Table UK Aurora Kinase A Sales (K Units) Market Share by Type (2012-2017)
Figure UK Aurora Kinase A Sales (K Units) Market Share by Type in 2017
Table UK Aurora Kinase A Sales (K Units) by Applications (2012-2017)
Table UK Aurora Kinase A Sales (K Units) Market Share by Applications (2012-2017)
Figure UK Aurora Kinase A Sales (K Units) Market Share by Applications in 2017
Figure France Aurora Kinase A Sales (K Units) and Growth Rate (2012-2017)
Figure France Aurora Kinase A Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure France Aurora Kinase A Sales Price (USD/Unit) Trend (2012-2017)
Table France Aurora Kinase A Sales (K Units) by Type (2012-2017)
Table France Aurora Kinase A Sales (K Units) Market Share by Type (2012-2017)
Figure France Aurora Kinase A Sales (K Units) Market Share by Type in 2017
Table France Aurora Kinase A Sales (K Units) by Applications (2012-2017)
Table France Aurora Kinase A Sales (K Units) Market Share by Applications (2012-2017)
Figure France Aurora Kinase A Sales (K Units) Market Share by Applications in 2017
Figure Russia Aurora Kinase A Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Aurora Kinase A Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Russia Aurora Kinase A Sales Price (USD/Unit) Trend (2012-2017)
Table Russia Aurora Kinase A Sales (K Units) by Type (2012-2017)
Table Russia Aurora Kinase A Sales (K Units) Market Share by Type (2012-2017)
Figure Russia Aurora Kinase A Sales (K Units) Market Share by Type in 2017
Table Russia Aurora Kinase A Sales (K Units) by Applications (2012-2017)
Table Russia Aurora Kinase A Sales (K Units) Market Share by Applications (2012-2017)
Figure Russia Aurora Kinase A Sales (K Units) Market Share by Applications in 2017
Figure Italy Aurora Kinase A Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Aurora Kinase A Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Italy Aurora Kinase A Sales Price (USD/Unit) Trend (2012-2017)
Table Italy Aurora Kinase A Sales (K Units) by Type (2012-2017)
Table Italy Aurora Kinase A Sales (K Units) Market Share by Type (2012-2017)
Figure Italy Aurora Kinase A Sales (K Units) Market Share by Type in 2017
Table Italy Aurora Kinase A Sales (K Units) by Applications (2012-2017)
Table Italy Aurora Kinase A Sales (K Units) Market Share by Applications (2012-2017)
Figure Italy Aurora Kinase A Sales (K Units) Market Share by Applications in 2017
Figure Benelux Aurora Kinase A Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Aurora Kinase A Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Benelux Aurora Kinase A Sales Price (USD/Unit) Trend (2012-2017)
Table Benelux Aurora Kinase A Sales (K Units) by Type (2012-2017)
Table Benelux Aurora Kinase A Sales (K Units) Market Share by Type (2012-2017)
Figure Benelux Aurora Kinase A Sales (K Units) Market Share by Type in 2017
Table Benelux Aurora Kinase A Sales (K Units) by Applications (2012-2017)
Table Benelux Aurora Kinase A Sales (K Units) Market Share by Applications (2012-2017)
Figure Benelux Aurora Kinase A Sales (K Units) Market Share by Applications in 2017
Figure Spain Aurora Kinase A Sales (K Units) and Growth Rate (2012-2017)
Figure Spain Aurora Kinase A Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Spain Aurora Kinase A Sales Price (USD/Unit) Trend (2012-2017)
Table Spain Aurora Kinase A Sales (K Units) by Type (2012-2017)
Table Spain Aurora Kinase A Sales (K Units) Market Share by Type (2012-2017)
Figure Spain Aurora Kinase A Sales (K Units) Market Share by Type in 2017
Table Spain Aurora Kinase A Sales (K Units) by Applications (2012-2017)
Table Spain Aurora Kinase A Sales (K Units) Market Share by Applications (2012-2017)
Figure Spain Aurora Kinase A Sales (K Units) Market Share by Applications in 2017
Table Distributors/Traders List
Figure Europe Aurora Kinase A Sales (K Units) and Growth Rate Forecast (2018-2023)
Figure Europe Aurora Kinase A Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Europe Aurora Kinase A Price and Trend Forecast (2018-2023)
Table Europe Aurora Kinase A Sales (K Units) Forecast by Regions (2018-2023)
Figure Europe Aurora Kinase A Sales (K Units) Market Share Forecast by Regions (2018-2023)
Figure Europe Aurora Kinase A Sales (K Units) Market Share Forecast by Regions in 2023
Table Europe Aurora Kinase A Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Europe Aurora Kinase A Revenue Market Share Forecast by Regions (2018-2023)
Figure Europe Aurora Kinase A Revenue Market Share Forecast by Regions in 2023
Figure Germany Aurora Kinase A Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Germany Aurora Kinase A Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure France Aurora Kinase A Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure France Aurora Kinase A Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure UK Aurora Kinase A Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure UK Aurora Kinase A Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Russia Aurora Kinase A Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Russia Aurora Kinase A Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Benelux Aurora Kinase A Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Benelux Aurora Kinase A Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Italy Aurora Kinase A Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Italy Aurora Kinase A Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Spain Aurora Kinase A Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Spain Aurora Kinase A Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Table Europe Aurora Kinase A Sales (K Units) Forecast by Type (2018-2023)
Figure Europe Aurora Kinase A Sales Market Share Forecast by Type (2018-2023)
Table Europe Aurora Kinase A Revenue (Million USD) Forecast by Type (2018-2023)
Figure Europe Aurora Kinase A Revenue Market Share Forecast by Type (2018-2023)
Table Europe Aurora Kinase A Price (USD/Unit) Forecast by Type (2018-2023)
Table Europe Aurora Kinase A Sales (K Units) Forecast by Application (2018-2023)
Figure Europe Aurora Kinase A Sales Market Share Forecast by Application (2018-2023)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources










Request Sample

* mark fields are compulsory